PMS AUM (in Rs. Cr)
5160
No. of PMS Products
0
No. of AIF Products
0
Data as of
30 June 2025
Investment DNA : What Makes Carnelian Different?
At Carnelian Asset Management, our unique investment philosophy is built on a foundation of rigorous analysis and a disciplined approach, setting us apart in the Indian equity landscape.
QGARP Lens : Quality, Growth, and Value Combined
Every Carnelian portfolio is crafted with a Quality-Growth At Reasonable Price (QGARP) lens. This powerful blend is further refined with two distinct sub-cohorts:
CLEAR Forensic Screen : Uncompromising Due Diligence
Our proprietary CLEAR forensic screen is a five-point audit every company must pass. This stringent process ensures the highest standards of corporate governance and financial health:
Aggressive accounting practices or high leverage are automatic exclusions, safeguarding your investments from undue risk.
Risk Management : Three-Bucket Approach
We meticulously manage risk by breaking it down into three distinct buckets, ensuring a comprehensive and proactive approach:
This granular approach to risk management typically results in shallower drawdowns compared to benchmarks.
Concentrated Conviction : Deep Due Diligence
Our portfolios maintain a focused approach, holding approximately 20–25 stocks. This concentration is strategic:
Why Partner with Carnelian Asset Management? Unmatched Value for Distributors
Listing Carnelian Asset Management on your platform provides your clients with access to a differentiated investment approach and robust support.
1. Cycle-Tested Absolute Returns
Our flagship strategies have consistently delivered strong, cycle-tested absolute returns:
● Capital Compounder:
○ PMS format: 18% CAGR since May 2019.
●Thematic Shift Strategy: Delivered an impressive 37.8% CAGR to PMS investors since 2020.
2. Product Breadth Under One Philosophy
Carnelian Asset Management offers a diverse range of products, all underpinned by our consistent and rigorous investment philosophy. This allows distributors to match nearly any client risk profile without concern for style drift:
● Core Multi-cap strategies
● Specialized manufacturing and technology plays
● Contrarian large-cap opportunities
● Bespoke 5-stock mandates
3. Forensic Comfort: A Tangible Risk Mitigation Story
The rigorous CLEAR due-diligence process provides relationship managers with a compelling and tangible risk-mitigation story for even the most cautious allocators. This transparency builds trust and confidence with clients.
4. High-Touch Partner Support
We’re committed to providing exceptional support to our partners:
●Monthly Factsheets: Detailed performance and portfolio insights.
●Daily NAV Feeds: Up-to-date net asset values for all strategies.
●Quarterly CIO Webinars: Direct insights from our Chief Investment Officers.
●Co-branded Decks: Customized marketing materials for large distributor events.
Carnelian Asset Management Product Offerings : Tailored Investment Solutions
Explore our comprehensive suite of investment products designed to cater to diverse investment goals and risk appetites within the Indian equity market.
Robust Risk Framework Across All Strategies
All Carnelian strategies adhere to a clear and transparent risk framework to protect client capital:
PMS Product Performance
Company Name / Product Name |
Category | Date of inception | AUM | 1y return | 2y return | 3y return | 5y return | 10y return | Since inception return |
---|---|---|---|---|---|---|---|---|---|
Carnelian Capital Compounder Strategy | Multi Cap | 15 May 2019 | 850 | 11.60% | 29.70% | 29.90% | 25.00% | - | 20.60% |
Carnelian Capital Shift | Mid & Small Cap | 06 Oct 2020 | 4200 | 14.50% | 32.50% | 37.40% | - | - | 38.70% |
Carnelian Capital Contra Portfolio Strategy | Multi Cap | 27 Jan 2022 | 110 | 2.20% | 34.90% | 38.20% | - | - | 32.40% |
Key People
Carnelian is a distinguished boutique investment firm established in 2019, specializing exclusively in Indian equities. We’re proudly founder-owned and currently manage an impressive USD 1.3 billion (₹10,800 crore). Our leadership team brings decades of invaluable market and corporate-access experience:

Mr. Vikas Khemani
CFA: Ex-Edelweiss CEO
Bringing strategic vision and leadership.

Mr. Manoj Bahety
CFA: A pioneer in forensic research
Ensuring robust due diligence
Supported by a dedicated 78-member team across seven Indian cities, we ensure comprehensive research, meticulous risk management, and efficient distribution. Our 100% internal ownership means our partners’ capital is invested alongside yours, guaranteeing full alignment of incentives.
PMS Product Performance
Company Name / Product Name |
Date of inception | AUM | 1y return | 2y return | 3y return | 5y return | 10y return | Since inception return |
---|---|---|---|---|---|---|---|---|
Carnelian Capital Compounder Strategy | 15 May 2019 | 850 | 11.60% | 29.70% | 29.90% | 25.00% | - | 20.60% |
Carnelian Capital Shift | 06 Oct 2020 | 4200 | 14.50% | 32.50% | 37.40% | - | - | 38.70% |
Carnelian Capital Contra Portfolio Strategy | 27 Jan 2022 | 110 | 2.20% | 34.90% | 38.20% | - | - | 32.40% |
Do Not Simply Invest, Make Informed Decisions
WISH TO MAKE INFORMED INVESTMENTS FOR LONG TERM WEALTH CREATION
